SCHEMBL5376792

SCHEMBL5376792

CCCCOc1ccc(COc2ccc(NS(=O)(=O)c3ccc(C)c(C(=O)OC)c3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.59
POLB P06746 2/20 0.54
LMNA P02545 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
PKM P14618 1/20 0.53
WDR5 P61964 1/20 0.52
AR P10275 2/20 0.50
PABPC1 P11940 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MAPK1 P28482 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
MGAT2 Q10469 1/20 0.46
HDAC1 Q13547 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380688 0.91 POLB (0.64) SMN1; SMN2POLBLMNAMEN1KMT2A
SCHEMBL5377045 0.88 SMN1; SMN2 (0.54) SMN1; SMN2POLBLMNAKMT2AWDR5
SCHEMBL5378800 0.88 SMN1; SMN2 (0.60) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5376600 0.87 MMP2 (0.55) SMN1; SMN2POLBLMNAMEN1KMT2A
SCHEMBL5375256 0.87 SMN1; SMN2 (0.62) SMN1; SMN2POLBLMNAWDR5PABPC1
SCHEMBL5373265 0.86 KMT2A (0.64) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5380794 0.86 SMN1; SMN2 (0.58) SMN1; SMN2POLBLMNAMEN1KMT2A
SCHEMBL5369902 0.85 SMN1; SMN2 (0.55) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL12598061 0.83 SMN1; SMN2 (0.83) SMN1; SMN2POLBLMNAWDR5ALDH1A1
SCHEMBL5391335 0.82 POLB (0.54) SMN1; SMN2POLBWDR5PABPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD SMN1; SMN2 3404/4885POLB 1807/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.